Advances in Research of Leptospirosis: Omics, Host-Pathogen Interactions, Immune Response and Mutagenesis

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".

Deadline for manuscript submissions: closed (15 February 2024) | Viewed by 5443

Special Issue Editors


E-Mail Website
Guest Editor
Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo 05503-900, Brazil
Interests: Leptospira; leptospirosis; functional genomics

E-Mail Website
Guest Editor
Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo 05503-900, Brazil
Interests: Leptospira; leptospirosis; functional genomics; host-pathogens interactions

E-Mail Website
Guest Editor
Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo 05503-900, Brazil
Interests: Leptospira; leptospirosis; host-pathogens interactions; genetic manipulation; virulence factors

Special Issue Information

Dear Colleagues,

Pathogenic Leptospira spp. are the etiologic agents of leptospirosis. The disease is the most spread zoonosis. The global burden of leptospirosis is estimated to be over one million annual cases. In developing countries, areas with inadequate infrastructure favor the proliferation of rats, the main reservoir of Leptospira. Infection occurs generally through direct or indirect contact with the urine of infected animals. Symptoms of leptospirosis are similar to acute febrile syndromes and, therefore, is misdiagnosed, and, most probably, underestimate. In developed countries, this disease is mostly associated with recreational activities or occupational activities. Leptospirosis has also an economic impact worldwide as it affects livestock, by decreasing milk production and causing premature death.

Currently, bacterin-based immunization using whole inactivated bacteria cells are the only options for the prevention of leptospirosis. Nevertheless, this approach is limited by a series of disadvantages involving short-term immunity and the absence of cross-reactivity among serovars. Difficulties involved to implement mutagenesis of Leptospira, allied to the lack of molecular aspects of leptospiral pathogenesis and immune response involved during leptospiral infection have impaired the development of effective strategies to control this disease.

This Research Topic aims to enhance our knowledge of mutagenesis, host–pathogen interactions, immune response mechanisms associated with pathogenic Leptospira in hosts. 

This includes: 

  • Identification of surface-exposed immunogenic targets;
  • Biological aspects of leptospiral mutagenesis;
  • Molecular and cellular aspects of host–pathogen interactions;
  • Animal models for the study of leptospiral mutants;
  • Immunization and protection against lethal infection in the hamster model of leptospirosis.

Dr. Ana L. T. O. Nascimento
Dr. Aline F. Teixeira
Dr. Luis G. V. Fernandes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Leptospira
  • leptospirosis
  • omics
  • neglected disease
  • host–pathogens interactions
  • mutagenesis
  • virulence factors

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 1593 KiB  
Article
LipL41 and LigA/LigB Gene Silencing on a LipL32 Knockout Leptospira interrogans Reveals the Impact of Multiple Mutations on Virulence
by Luis Guilherme V. Fernandes, Bruno B. Foltran, Aline F. Teixeira and Ana Lucia Tabet Oller Nascimento
Pathogens 2023, 12(10), 1191; https://doi.org/10.3390/pathogens12101191 - 24 Sep 2023
Cited by 1 | Viewed by 1066
Abstract
Leptospirosis is a global zoonosis caused by pathogenic bacteria of the genus Leptospira. The application of the CRISPR/Cas9 system has facilitated the generation of mutants and subsequent evaluation of phenotypes. Since DNA breaks induced by RNA-guided Cas9 nuclease are lethal to Leptospira [...] Read more.
Leptospirosis is a global zoonosis caused by pathogenic bacteria of the genus Leptospira. The application of the CRISPR/Cas9 system has facilitated the generation of mutants and subsequent evaluation of phenotypes. Since DNA breaks induced by RNA-guided Cas9 nuclease are lethal to Leptospira, different methodologies were implemented to overcome this limitation. Initially, CRISPR interference (CRISPRi) was employed to create knockdown mutants, utilizing a catalytically inactive Cas9 (dCas9). Subsequently, the co-expression of CRISPR/Cas9 and a DNA repair system from Mycobacterium smegmatis enabled the generation of scarless knockout mutants. We eliminated plasmids from the lipL32 knockout L. interrogans strain and further achieved multiple gene mutations via gene silencing in this knockout background. Strains lacking both LipL41 and LipL32 and LigA, LigB, and LipL32, were evaluated. The absence of proteins LipL32 and LipL41 had no effect on leptospiral virulence. On the other hand, mutants lacking LigA, LigB, and LipL32 were unable to cause acute disease. The expanded apparatus for genetic manipulation of pathogenic leptospires via the CRISPR/Cas9 system has allowed the evaluation of multiple mutations upon leptospiral virulence. This work shows that LipL32 and LipL41 are not required for acute disease and consolidates LigA and LigB proteins as virulence factors. Full article
Show Figures

Figure 1

9 pages, 1246 KiB  
Communication
Ancestral African Bats Brought Their Cargo of Pathogenic Leptospira to Madagascar under Cover of Colonization Events
by Colette Cordonin, Yann Gomard, Ara Monadjem, M. Corrie Schoeman, Gildas Le Minter, Erwan Lagadec, Eduardo S. Gudo, Steven M. Goodman, Koussay Dellagi, Patrick Mavingui and Pablo Tortosa
Pathogens 2023, 12(7), 859; https://doi.org/10.3390/pathogens12070859 - 21 Jun 2023
Viewed by 962
Abstract
Madagascar is home to an extraordinary diversity of endemic mammals hosting several zoonotic pathogens. Although the African origin of Malagasy mammals has been addressed for a number of volant and terrestrial taxa, the origin of their hosted zoonotic pathogens is currently unknown. Using [...] Read more.
Madagascar is home to an extraordinary diversity of endemic mammals hosting several zoonotic pathogens. Although the African origin of Malagasy mammals has been addressed for a number of volant and terrestrial taxa, the origin of their hosted zoonotic pathogens is currently unknown. Using bats and Leptospira infections as a model system, we tested whether Malagasy mammal hosts acquired these infections on the island following colonization events, or alternatively brought these bacteria from continental Africa. We first described the genetic diversity of pathogenic Leptospira infecting bats from Mozambique and then tested through analyses of molecular variance (AMOVA) whether the genetic diversity of Leptospira hosted by bats from Mozambique, Madagascar and Comoros is structured by geography or by their host phylogeny. This study reveals a wide diversity of Leptospira lineages shed by bats from Mozambique. AMOVA strongly supports that the diversity of Leptospira sequences obtained from bats sampled in Mozambique, Madagascar, and Comoros is structured according to bat phylogeny. Presented data show that a number of Leptospira lineages detected in bat congeners from continental Africa and Madagascar are imbedded within monophyletic clades, strongly suggesting that bat colonists have indeed originally crossed the Mozambique Channel while infected with pathogenic Leptospira. Full article
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 794 KiB  
Review
Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy
by Natasha Rodrigues de Oliveira, Francisco Denis Souza Santos, Vitória Adrielly Catschor dos Santos, Mara Andrade Colares Maia, Thaís Larré Oliveira and Odir Antônio Dellagostin
Pathogens 2023, 12(6), 787; https://doi.org/10.3390/pathogens12060787 - 31 May 2023
Cited by 4 | Viewed by 2991
Abstract
The first leptospiral recombinant vaccine was developed in the late 1990s. Since then, progress in the fields of reverse vaccinology (RV) and structural vaccinology (SV) has significantly improved the identification of novel surface-exposed and conserved vaccine targets. However, developing recombinant vaccines for leptospirosis [...] Read more.
The first leptospiral recombinant vaccine was developed in the late 1990s. Since then, progress in the fields of reverse vaccinology (RV) and structural vaccinology (SV) has significantly improved the identification of novel surface-exposed and conserved vaccine targets. However, developing recombinant vaccines for leptospirosis faces various challenges, including selecting the ideal expression platform or delivery system, assessing immunogenicity, selecting adjuvants, establishing vaccine formulation, demonstrating protective efficacy against lethal disease in homologous challenge, achieving full renal clearance using experimental models, and reproducibility of protective efficacy against heterologous challenge. In this review, we highlight the role of the expression/delivery system employed in studies based on the well-known LipL32 and leptospiral immunoglobulin-like (Lig) proteins, as well as the choice of adjuvants, as key factors to achieving the best vaccine performance in terms of protective efficacy against lethal infection and induction of sterile immunity. Full article
Show Figures

Figure 1

Back to TopTop